RD
Riccardo Di Sanza
UCB Pharma (Belgium), Sygnature Discovery (Canada), University of Nottingham, Università degli Studi Gabriele d'Annunzio Chieti e Pescara Dipartimento di Farmacia, Sygnature Discovery Ltd
Research areas: Chemistry · Organic Chemistry · Asymmetric Synthesis and Catalysis · Crystal structures of chemical compounds · Crystallography and molecular interactions
0000-0002-5667-902X
Employment
-
UCB Pharma (Belgium) Senior Scientist2025 - Present
-
Sygnature Discovery Lead Scientist2025 - 2025
-
Sygnature Discovery Ltd Senior Scientist2021 - 2025
-
Institut Català d'Investigació Química Postdoctoral Researcher2020 - 2021
Education
- 2015 - 2019
-
Università degli Studi Gabriele d'Annunzio Chieti e Pescara Dipartimento di Farmacia Master's degree in Medicinal Chemistry2007 - 2013
Projects & Funding
Projects & funding information is unavailable.
Publications (4)
- Photoredox Organocatalysis for the Enantioselective Synthesis of 1,7-Dicarbonyl Compounds Save
- Understanding the Diastereopreference of Intermediates in Aminocatalysis: Application to the Chiral Resolution of Lactols Save
- Photochemical Chemoselective Alkylation of Tryptophan-Containing Peptides Save
- Enantioselective nickel-catalyzed arylative and alkenylative intramolecular 1,2-allylations of tethered allene–ketones Save